Li et al. 2022 (PRJNA633140)
General Details
Title | eIF4A2 targets developmental potency and histone H3.3 transcripts for translational control of embryonic and cancer stemness [Ribo-seq] |
---|---|
Organism | |
Number of Samples | 16 |
Release Date | 2020/05/15 00:00 |
Sequencing Types | |
Protocol Details |
Study Links
GWIPS-viz | Trips-Viz |
---|---|
Repository Details
SRA | SRP261884 |
---|---|
ENA | SRP261884 |
GEO | GSE150676 |
BioProject | PRJNA633140 |
Publication
Title | |
---|---|
Authors | Li D, Yang J, Huang X, Zhou H, Wang J |
Journal | Science advances |
Publication Date | 2022 Apr |
Abstract | Translational control has emerged as a fundamental regulatory layer of proteome complexity that governs cellular identity and functions. As initiation is the rate-limiting step of translation, we carried out an RNA interference screen for key translation initiation factors required to maintain embryonic stem cell (ESC) identity. We identified eukaryotic translation initiation factor 4A2 (eIF4A2) and defined its mechanistic action through ribosomal protein S26-independent and -dependent ribosomes in translation initiation activation of messenger RNAs (mRNAs) encoding pluripotency factors and the histone variant H3.3 with demonstrated roles in maintaining stem cell pluripotency. eIF4A2 also mediates translation initiation activation of Ddx6, which acts together with eIF4A2 to restrict the totipotent two-cell transcription program in ESCs through Zscan4 mRNA degradation and translation repression. Accordingly, knockdown of eIF4A2 disrupts ESC proteome, causing the loss of ESC identity. Collectively, we establish a translational paradigm of the protein synthesis of pluripotency transcription factors and epigenetic regulators imposed on their established roles in controlling pluripotency. |
PMC | PMC8967233 |
PMID | 35353581 |
DOI |
Run Accession | Study Accession | Scientific Name | Cell Line | Library Type | Treatment | GWIPS-viz | Trips-Viz | Reads | BAM | BigWig (F) | BigWig (R) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SRR11798518 | PRJNA633140 | Mus musculus | mESC | Ribo-Seq | 0.0 | ||||||||
SRR11798519 | PRJNA633140 | Mus musculus | mESC | Ribo-Seq | 0.0 | ||||||||
SRR11798520 | PRJNA633140 | Mus musculus | mESC | Ribo-Seq | 0.0 | ||||||||
SRR11798521 | PRJNA633140 | Mus musculus | mESC | Ribo-Seq | 0.0 | ||||||||
SRR11798522 | PRJNA633140 | Mus musculus | mESC | Ribo-Seq | 0.0 | ||||||||
SRR11798523 | PRJNA633140 | Mus musculus | mESC | Ribo-Seq | 0.0 | ||||||||
SRR11798524 | PRJNA633140 | Mus musculus | mESC | Ribo-Seq | 0.0 | ||||||||
SRR11798525 | PRJNA633140 | Mus musculus | mESC | Ribo-Seq | 0.0 | ||||||||
SRR11798526 | PRJNA633140 | Mus musculus | mESC | Ribo-Seq | 0.0 | ||||||||
SRR11798527 | PRJNA633140 | Mus musculus | mESC | Ribo-Seq | 0.0 | ||||||||
SRR11798528 | PRJNA633140 | Mus musculus | mESC | Ribo-Seq | 0.0 | ||||||||
SRR11798529 | PRJNA633140 | Mus musculus | mESC | Ribo-Seq | 0.0 | ||||||||
SRR11798530 | PRJNA633140 | Mus musculus | mESC | Ribo-Seq | 0.0 | ||||||||
SRR11798531 | PRJNA633140 | Mus musculus | mESC | Ribo-Seq | 0.0 | ||||||||
SRR11798532 | PRJNA633140 | Mus musculus | mESC | Ribo-Seq | 0.0 | ||||||||
SRR11798533 | PRJNA633140 | Mus musculus | mESC | Ribo-Seq | 0.0 | ||||||||
Run Accession | Study Accession | Scientific Name | Cell Line | Library Type | Treatment | GWIPS-viz | Trips-Viz | Reads | BAM | BigWig (F) | BigWig (R) |
ⓘ For more Information on the columns shown here see: About